Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
IVERIC bio, Inc. (OPHT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/21/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 07/18/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/13/2023 |
4
| Blumenkranz Mark S. (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 32,088 shares
@ $0
Disposed/sold 5,000 restricted stock units
@ $0
Disposed/sold 7,500 restricted stock units
@ $0
Disposed/sold 31,000 options to buy
@ $4.48, valued at
$138.9k
Disposed/sold 15,500 options to buy
@ $6.82, valued at
$105.7k
Disposed/sold 23,186 options to buy
@ $9.94, valued at
$230.5k
|
|
| 07/13/2023 |
4
| Carroll David Francis (SVP, CFO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 44,152 shares
@ $0
Disposed/sold 10,000 restricted stock units
@ $0
Disposed/sold 28,750 restricted stock units
@ $0
Disposed/sold 26,250 restricted stock units
@ $0
Disposed/sold 37,500 restricted stock units
@ $0
Disposed/sold 55,000 options to buy
@ $52.71, valued at
$2.9M
Disposed/sold 38,000 options to buy
@ $4.5, valued at
$171k
Disposed/sold 150,000 options to buy
@ $2.94, valued at
$441k
Disposed/sold 75,000 options to buy
@ $5.22, valued at
$391.5k
Disposed/sold 115,000 options to buy
@ $7.5, valued at
$862.5k
Disposed/sold 70,000 options to buy
@ $14.83, valued at
$1M
|
|
| 07/13/2023 |
4
| Miller Christine Ann (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 13,075 shares
@ $0
Disposed/sold 10,000 restricted stock units
@ $0
Disposed/sold 7,500 restricted stock units
@ $0
Disposed/sold 31,000 options to buy
@ $14.31, valued at
$443.6k
Disposed/sold 12,835 options to buy
@ $9.94, valued at
$127.6k
|
|
| 07/13/2023 |
4
| Graves Adrienne L (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 22,088 shares
@ $0
Disposed/sold 7,500 restricted stock units
@ $0
Disposed/sold 32,000 options to buy
@ $1.45, valued at
$46.4k
Disposed/sold 16,000 options to buy
@ $1.39, valued at
$22.2k
Disposed/sold 16,000 options to buy
@ $4.14, valued at
$66.2k
Disposed/sold 15,500 options to buy
@ $6.82, valued at
$105.7k
Disposed/sold 23,186 options to buy
@ $9.94, valued at
$230.5k
|
|
| 07/13/2023 |
4
| Roberts Calvin W. (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 47,088 shares
@ $0
Disposed/sold 7,500 restricted stock units
@ $0
Disposed/sold 32,000 options to buy
@ $1.2, valued at
$38.4k
Disposed/sold 16,000 options to buy
@ $1.39, valued at
$22.2k
Disposed/sold 16,000 options to buy
@ $4.14, valued at
$66.2k
Disposed/sold 15,500 options to buy
@ $6.82, valued at
$105.7k
Disposed/sold 23,186 options to buy
@ $9.94, valued at
$230.5k
|
|
| 07/13/2023 |
4
| SBLENDORIO GLENN (CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 239,275 shares
@ $0
Disposed/sold 23,750 restricted stock units
@ $0
Disposed/sold 73,315 restricted stock units
@ $0
Disposed/sold 94,500 restricted stock units
@ $0
Disposed/sold 150,000 restricted stock units
@ $0
Disposed/sold 6,949 options to buy
@ $33.27, valued at
$231.2k
Disposed/sold 15,000 options to buy
@ $37, valued at
$555k
Disposed/sold 7,000 options to buy
@ $48.3, valued at
$338.1k
Disposed/sold 150,000 options to buy
@ $44.9, valued at
$6.7M
Disposed/sold 260,000 options to buy
@ $4.52, valued at
$1.2M
Disposed/sold 325,000 options to buy
@ $2.94, valued at
$955.5k
|
|
| 07/13/2023 |
4
| Simms Christopher Paul (SVP, Chief Commercial Officer) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 32,429 shares
@ $0
Disposed/sold 56,250 restricted stock units
@ $0
Disposed/sold 18,750 restricted stock units
@ $0
Disposed/sold 37,500 restricted stock units
@ $0
Disposed/sold 160,000 options to buy
@ $8.64, valued at
$1.4M
Disposed/sold 50,000 options to buy
@ $14.83, valued at
$741.5k
Disposed/sold 75,000 options to buy
@ $22.57, valued at
$1.7M
|
|
| 07/13/2023 |
4
| Dugel Pravin (President) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 203,035 shares
@ $0
Disposed/sold 8,625 restricted stock units
@ $0
Disposed/sold 50,000 restricted stock units
@ $0
Disposed/sold 37,500 restricted stock units
@ $0
Disposed/sold 70,000 restricted stock units
@ $0
Disposed/sold 27,500 restricted stock units
@ $0
Disposed/sold 300,000 options to buy
@ $3.16, valued at
$948k
Disposed/sold 110,000 options to buy
@ $7.5, valued at
$825k
Disposed/sold 35,000 options to buy
@ $7.17, valued at
$251k
Disposed/sold 100,000 options to buy
@ $14.83, valued at
$1.5M
Disposed/sold 140,000 options to buy
@ $22.57, valued at
$3.2M
|
|
| 07/13/2023 |
4
| Henderson Jane (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 22,088 shares
@ $0
Disposed/sold 7,500 restricted stock units
@ $0
Disposed/sold 32,000 options to buy
@ $2.85, valued at
$91.2k
Disposed/sold 16,000 options to buy
@ $2.775, valued at
$44.4k
Disposed/sold 16,000 options to buy
@ $1.39, valued at
$22.2k
Disposed/sold 16,000 options to buy
@ $4.14, valued at
$66.2k
Disposed/sold 15,500 options to buy
@ $6.82, valued at
$105.7k
Disposed/sold 23,186 options to buy
@ $9.94, valued at
$230.5k
|
|
| 07/13/2023 |
4
| Westby Keith (SVP, COO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 39,652 shares
@ $0
Disposed/sold 10,000 restricted stock units
@ $0
Disposed/sold 25,000 restricted stock units
@ $0
Disposed/sold 26,250 restricted stock units
@ $0
Disposed/sold 37,500 restricted stock units
@ $0
Disposed/sold 67,250 options to buy
@ $31.29, valued at
$2.1M
Disposed/sold 6,250 options to buy
@ $45.6, valued at
$285k
Disposed/sold 11,000 options to buy
@ $73.22, valued at
$805.4k
Disposed/sold 80,000 options to buy
@ $2.94, valued at
$235.2k
Disposed/sold 63,786 options to buy
@ $5.22, valued at
$333k
Disposed/sold 100,000 options to buy
@ $7.5, valued at
$750k
|
|
| 07/13/2023 |
4
| Gibney Anthony S (EVP, Chief Business Officer) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 40,291 shares
@ $0
Disposed/sold 75,000 restricted stock units
@ $0
Disposed/sold 25,000 restricted stock units
@ $0
Disposed/sold 56,250 restricted stock units
@ $0
Disposed/sold 200,000 options to buy
@ $15.16, valued at
$3M
Disposed/sold 50,000 options to buy
@ $22.57, valued at
$1.1M
|
|
| 07/13/2023 |
4
| Bolte Axel (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 22,088 shares
@ $0
Disposed/sold 7,500 restricted stock units
@ $0
Disposed/sold 16,000 options to buy
@ $2.46, valued at
$39.4k
Disposed/sold 16,000 options to buy
@ $2.775, valued at
$44.4k
Disposed/sold 16,000 options to buy
@ $1.39, valued at
$22.2k
Disposed/sold 16,000 options to buy
@ $4.14, valued at
$66.2k
Disposed/sold 15,500 options to buy
@ $6.82, valued at
$105.7k
Disposed/sold 23,186 options to buy
@ $9.94, valued at
$230.5k
|
|
| 07/11/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2023 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 07/11/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
|
|
|